Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes
Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes
复制标题
DOI：
10.1089/dia.2020.0237
复制
发表时间：
2020-07-15
影响因子：
5.4
通讯作者：
Fukui, Michiaki
中科院分区：
文献类型：
--
作者：
Ushigome, Emi;Yamazaki, Masahiro;Fukui, Michiaki
糖尿病与冠状病毒病(新冠肺炎)的死亡率和严重程度有关。预防感染新冠肺炎高危医护人员至关重要。这份报告调查了远程持续血糖监测(CGM)在糖尿病和由冠状病毒病引起的严重间质性肺炎患者中的有效性和安全性。Dexcom G4白金CGM系统(R)用于在患者隔离室外监测血糖(BG)水平。根据患者的血糖水平确定持续的胰岛素输注率和剂量。实时CGM使追踪血糖趋势和防止血糖剧烈变化成为可能，尽管胰岛素输注速度是动态变化的。此外，由于Dexcom G4白金CGM系统可以在长达6.0米的距离内进行评估，因此最大限度地减少了医护人员进入隔离室的需要。
Diabetes is associated with mortality and severity of coronavirus disease (COVID-19). Protecting against infection in health care workers at high risk of COVID-19 is critical. This report investigates the usefulness and safety of remote continuous glucose monitoring (CGM) in a patient with diabetes and severe interstitial pneumonia caused by the coronavirus disease. The Dexcom G4 Platinum CGM system(R)was used to monitor blood glucose (BG) levels from outside the patient's isolation room. Continuous insulin infusion rates and boluses were determined based on the patient's BG levels. Real-time CGM made it possible to track BG trends and prevent dramatic variations in BG, although the rate of insulin infusion changed dynamic. Furthermore, the need for health care workers to enter the isolation room was minimized because the Dexcom G4 Platinum CGM system can evaluate from a distance of up to 6.0 m.